A landmark book that shows us exactly how we have let health and medicine become a crisis in our society and what we can all do to resolve it Healthcare is no longer just a public issue; for millions of Americans it is now a crisis on their own doorstep. Costs of medical care today are a leading cause personal bankruptcy. Although policy makers have weighed in on all sides, in this book, bestselling author Andrew Weil, M.D. identifies the root of the problem. He shows us exactly how we have become embroiled in the present situation and provides a solution that will not only make healthcare affordable, but will also put each one of us on the road to optimum health. Dr. Weil states that we have a right to good healthcare that is effective, accessible, and affordable. Many Americans would be surprised to know that our national health is far from the best in the world, even though we spend more money on it than any other country. The World Health Organization recently rated America thirty-seventh in health outcomes, on par with Serbia. Tackling head-on The Three Major Myths of American Medicine, Dr. Weil shows how medical schools fail to give future doctors the education they need to care for patients, how insurance companies have destroyed our opportunity to get excellent care, and how pharmaceutical companies have come to rule our lives. The solution involves nothing less than the creation of a completely new culture of health and medicine in this country, one that we can each start building today.

"A collection of diverse viewpoints from over 45 thought leaders in the biotechnology industry and their efforts going forward during the COVID-19 pandemic. Biotechnology in the Time of COVID-19 is the opening chapter of a story of how the biotechnology industry rose to battle the COVID-19 virus-told by the leaders of that industry in their own words. The industry has built over more than forty years, an ecosystem of scientists, entrepreneurs, doctors, investors, venture capitalists, analysts, media, and bankers, all committed to advancing global health. In two months, leaders and companies from this ecosystem pivoted from the work they were carrying on pre-COVID-19 to face the virus. Forty-six seven contributors offer historical, personal, and investor perspectives, views from inside the biotech companies, broad lessons, leadership, and a look to the future. COVID-19 was a crisis anticipated by many, but one for which we were inadequately prepared. That has led to an unnecessary catastrophe. Now is the time to shine a light on those who bring hope that we will push back the virus with science and medicine. This book is a collection of the voices from the front of that fight. All share the commitment to fight and the conviction that science and medicine will prevail. The editor royalties and a portion of publisher revenues will be donated to two nonprofits focused on rare disease research: Global Genes (globalgenes.org) and The Institute for Life Changing Medicines (lifechangingmedicines.org)"--

“ Blood Feud rivals A Civil Action for best non-fiction book of the past twenty years.” — John Lescroart, New York Times bestselling author of Damage Procrit seemed like a biotech miracle, promising a golden age in medical care. Developed in the 1980s by Amgen and licensed to the pharmaceutical giant, Johnson & Johnson, the drug (AKA Epogen and Aranesp) soon generated billions in annual revenue—and still does. In 2012, world famous cyclist, Olympian, and Tour de France champion Lance Armstrong was banned from professional cycling on doping charges for using EPO (the blanket name for the drugs Procrit and Epogen), resulting in a global controversy about abuse, big pharmaceutical companies, and the lies and inaccuracies concerning performance-enhancing drugs. Mark Duxbury was a J&J salesman who once believed in the blood-booster, setting record sales and winning company awards. Then Duxbury started to learn unsavory truths about Procrit and J&J’s business practices. He was fired and filed a whistleblower suit to warn the public. When Jan Schlichtman ( A Civil Action ) learned of Duxbury’s crusade, he signed on. Now, he’s fighting on behalf of cancer patients and for every American who trusts Big Pharma with his life.